Literature DB >> 20038537

Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease.

Mike Tsz Hin Ng1, Rob Van't Hof, Julie C Crockett, Mairi E Hope, Susan Berry, John Thomson, Mairi H McLean, Kenneth E L McColl, Emad M El-Omar, Georgina L Hold.   

Abstract

Colonization of the gastric mucosa by Helicobacter pylori can lead to serious clinical outcomes, including gastric cancer. Toll-like receptors (TLRs) play an important role in the host response to H. pylori through the recognition of pathogen-associated molecular patterns. TLR9, in particular, is partly responsible for initiating bacterial induced immunity by binding unmethylated CpG-DNA, which is abundant in bacteria. A well-documented single nucleotide polymorphism (SNP) within the TLR9 promoter (TLR9 -1237T/C), is associated with a variety of inflammatory disorders, including allergic asthma, inflammatory bowel disease, and atopy. Analysis of the TLR9 promoter gene sequence has shown that carriage of the variant "C" allele at position -1237 creates a potential NF-kappaB binding site that would theoretically increase the transcriptional activity of the gene. In this study, we report that the TLR9 -1237 C allele was significantly associated with the development of H. pylori-induced premalignant gastric changes. Functional analysis of the SNP, supporting the data generated from the genetic association study, showed that carriage of the C allele increased TLR9 transcriptional activity driven mainly by activation of NF-kappaB. Collectively, these findings confirm that the TLR9 -1237T/C polymorphism is a risk factor for the development of H. pylori-induced premalignant gastric changes and provide a plausible mechanistic explanation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20038537      PMCID: PMC2825916          DOI: 10.1128/IAI.01226-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  CpG motifs in bacterial DNA and their immune effects.

Authors:  Arthur M Krieg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 3.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

Review 4.  Helicobacter pylori and gastrointestinal tract adenocarcinomas.

Authors:  Richard M Peek; Martin J Blaser
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

5.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

6.  Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori.

Authors:  E M El-Omar; K Oien; L S Murray; A El-Nujumi; A Wirz; D Gillen; C Williams; G Fullarton; K E McColl
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

7.  Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.

Authors:  A Krug; A Towarowski; S Britsch; S Rothenfusser; V Hornung; R Bals; T Giese; H Engelmann; S Endres; A M Krieg; G Hartmann
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

8.  Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies.

Authors:  Ross Lazarus; Walter T Klimecki; Benjamin A Raby; Donata Vercelli; Lyle J Palmer; David J Kwiatkowski; Edwin K Silverman; Fernando Martinez; Scott T Weiss
Journal:  Genomics       Date:  2003-01       Impact factor: 5.736

9.  Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway.

Authors:  Shin-Ichi Yokota; Tamaki Okabayashi; Michael Rehli; Nobuhiro Fujii; Ken-Ichi Amano
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

10.  Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells.

Authors:  Manuel R Amieva; Nina R Salama; Lucy S Tompkins; Stanley Falkow
Journal:  Cell Microbiol       Date:  2002-10       Impact factor: 3.715

View more
  44 in total

Review 1.  Microbial Nucleic Acid Sensing in Oral and Systemic Diseases.

Authors:  K E Crump; S E Sahingur
Journal:  J Dent Res       Date:  2015-10-05       Impact factor: 6.116

2.  Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection.

Authors:  Yuko Yamaguchi; James A Harker; Belinda Wang; Peter J Openshaw; John S Tregoning; Fiona J Culley
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

3.  Polymorphisms of Toll-like receptor 9 are associated with nasopharyngeal carcinoma susceptibility.

Authors:  Qiong Dai; Xing Pu Li; Li Chai; Han An Long; Zhi Hui Yang
Journal:  Tumour Biol       Date:  2014-02-07

Review 4.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 5.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

6.  Association of Toll-Like Receptor 3 and Toll-Like Receptor 9 Single Nucleotide Polymorphisms with Hepatitis C Virus Infection and Hepatic Fibrosis in Egyptian Patients.

Authors:  Rania A Zayed; Dalia Omran; Doha A Mokhtar; Zinab Zakaria; Sameera Ezzat; Mohamed A Soliman; Lamiaa Mobarak; Hossam El-Sweesy; Ghada Emam
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

7.  The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma.

Authors:  A Carvalho; C Cunha; A J Almeida; N S Osório; M Saraiva; M Teixeira-Coelho; S Pedreiro; E Torrado; N Domingues; A G Gomes-Alves; A Marques; J F Lacerda; M G da Silva; M Gomes; A C Pinto; F Torres; P Rendeiro; P Tavares; M Di Ianni; R Medeiros; P Heutink; P M Bracci; L Conde; P Ludovico; J Pedrosa; P Maciel; L Pitzurra; F Aversa; H Marques; A Paiva; C F Skibola; L Romani; A G Castro; F Rodrigues
Journal:  Genes Immun       Date:  2011-08-25       Impact factor: 2.676

8.  Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice.

Authors:  Mark T Whary; Nancy S Taylor; Yan Feng; Zhongming Ge; Suresh Muthupalani; James Versalovic; James G Fox
Journal:  Immunology       Date:  2011-03-23       Impact factor: 7.397

9.  Polymorphisms in the Fc gamma receptor IIIA and Toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon levels.

Authors:  Elly O Munde; Winnie A Okeyo; Samwel B Anyona; Evans Raballah; Stephen Konah; Wilson Okumu; Lilian Ogonda; John Vulule; Collins Ouma
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

Review 10.  The Protective Effects of Helicobacter pylori Infection on Allergic Asthma.

Authors:  Zhi Tong Zuo; Ya Ma; Yan Sun; Cui Qing Bai; Chun Hua Ling; Feng Lai Yuan
Journal:  Int Arch Allergy Immunol       Date:  2020-10-20       Impact factor: 2.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.